Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response

Christoph I. Lee, Laura S. Gold, Heidi Nelson, Roger Chou, Scott D. Ramsey, Sean D. Sullivan

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We performed a systematic review to address the comparative effectiveness of different imaging modalities in evaluating treatment response among metastatic breast cancer patients. We searched seven multidisciplinary electronic databases for relevant publications (January 2003-December 2013) and performed dual abstraction of details and results for all clinical studies that involved stage IV breast cancer patients and evaluated imaging for detecting treatment response. Among 159 citations reviewed, 17 single-institution, non-randomized, observational studies met our inclusion criteria. Several studies demonstrate that changes in PET/CT standard uptake values are associated with changes in tumor volume as determined by bone scan, MRI, and/or CT. However, no studies evaluated comparative test performance between modalities or determined relationships between imaging findings and subsequent clinical decisions. Evidence for imaging's effectiveness in determining treatment response among metastatic breast cancer patients is limited. More rigorous research is needed to address imaging's value in this patient population.

Original languageEnglish (US)
Pages (from-to)3-11
Number of pages9
JournalBreast
Volume24
Issue number1
DOIs
StatePublished - Feb 1 2015

Fingerprint

Breast Neoplasms
Therapeutics
Tumor Burden
Observational Studies
Publications
Magnetic Resonance Imaging
Databases
Bone and Bones
Research
Population
Clinical Studies

Keywords

  • Bone scan
  • Computed tomography
  • Metastatic breast cancer
  • Positron emission tomography
  • Treatment response

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. / Lee, Christoph I.; Gold, Laura S.; Nelson, Heidi; Chou, Roger; Ramsey, Scott D.; Sullivan, Sean D.

In: Breast, Vol. 24, No. 1, 01.02.2015, p. 3-11.

Research output: Contribution to journalArticle

Lee, Christoph I. ; Gold, Laura S. ; Nelson, Heidi ; Chou, Roger ; Ramsey, Scott D. ; Sullivan, Sean D. / Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. In: Breast. 2015 ; Vol. 24, No. 1. pp. 3-11.
@article{c14a7dba13694ead97033d4577f9a180,
title = "Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response",
abstract = "We performed a systematic review to address the comparative effectiveness of different imaging modalities in evaluating treatment response among metastatic breast cancer patients. We searched seven multidisciplinary electronic databases for relevant publications (January 2003-December 2013) and performed dual abstraction of details and results for all clinical studies that involved stage IV breast cancer patients and evaluated imaging for detecting treatment response. Among 159 citations reviewed, 17 single-institution, non-randomized, observational studies met our inclusion criteria. Several studies demonstrate that changes in PET/CT standard uptake values are associated with changes in tumor volume as determined by bone scan, MRI, and/or CT. However, no studies evaluated comparative test performance between modalities or determined relationships between imaging findings and subsequent clinical decisions. Evidence for imaging's effectiveness in determining treatment response among metastatic breast cancer patients is limited. More rigorous research is needed to address imaging's value in this patient population.",
keywords = "Bone scan, Computed tomography, Metastatic breast cancer, Positron emission tomography, Treatment response",
author = "Lee, {Christoph I.} and Gold, {Laura S.} and Heidi Nelson and Roger Chou and Ramsey, {Scott D.} and Sullivan, {Sean D.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.breast.2014.11.009",
language = "English (US)",
volume = "24",
pages = "3--11",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response

AU - Lee, Christoph I.

AU - Gold, Laura S.

AU - Nelson, Heidi

AU - Chou, Roger

AU - Ramsey, Scott D.

AU - Sullivan, Sean D.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - We performed a systematic review to address the comparative effectiveness of different imaging modalities in evaluating treatment response among metastatic breast cancer patients. We searched seven multidisciplinary electronic databases for relevant publications (January 2003-December 2013) and performed dual abstraction of details and results for all clinical studies that involved stage IV breast cancer patients and evaluated imaging for detecting treatment response. Among 159 citations reviewed, 17 single-institution, non-randomized, observational studies met our inclusion criteria. Several studies demonstrate that changes in PET/CT standard uptake values are associated with changes in tumor volume as determined by bone scan, MRI, and/or CT. However, no studies evaluated comparative test performance between modalities or determined relationships between imaging findings and subsequent clinical decisions. Evidence for imaging's effectiveness in determining treatment response among metastatic breast cancer patients is limited. More rigorous research is needed to address imaging's value in this patient population.

AB - We performed a systematic review to address the comparative effectiveness of different imaging modalities in evaluating treatment response among metastatic breast cancer patients. We searched seven multidisciplinary electronic databases for relevant publications (January 2003-December 2013) and performed dual abstraction of details and results for all clinical studies that involved stage IV breast cancer patients and evaluated imaging for detecting treatment response. Among 159 citations reviewed, 17 single-institution, non-randomized, observational studies met our inclusion criteria. Several studies demonstrate that changes in PET/CT standard uptake values are associated with changes in tumor volume as determined by bone scan, MRI, and/or CT. However, no studies evaluated comparative test performance between modalities or determined relationships between imaging findings and subsequent clinical decisions. Evidence for imaging's effectiveness in determining treatment response among metastatic breast cancer patients is limited. More rigorous research is needed to address imaging's value in this patient population.

KW - Bone scan

KW - Computed tomography

KW - Metastatic breast cancer

KW - Positron emission tomography

KW - Treatment response

UR - http://www.scopus.com/inward/record.url?scp=84920486555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920486555&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2014.11.009

DO - 10.1016/j.breast.2014.11.009

M3 - Article

C2 - 25479913

AN - SCOPUS:84920486555

VL - 24

SP - 3

EP - 11

JO - Breast

JF - Breast

SN - 0960-9776

IS - 1

ER -